Complete Filing Data
International Media Acquisition Corp. reported Stockholders Equity of -$11.05 million for FY2023.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean International Media Acquisition Corp. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Income * | -$408.1K | -$814.5K | -$1.2M | -$2.2M | -$1.9M |
| Operating Income Loss | -$943.2K | -$1.9M | -$2.2M | -$2.1M | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$285.4K | -$596.2K | -$1.0M | -$1.9M | |
| Income Tax Expense Benefit | $122.8K | $218.3K | $207.6K | $0.00 | $0.00 |
| Accrued Income Taxes Current | $425.9K | $207.6K | $0.00 | $0.00 | |
| General And Administrative Expense | $734.8K | $1.7M | $2.0M | ||
| Sales And Excise Tax Payable Current | $113.7K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$59.6K | -$97.0K | -$120.1K | -$160.1K | -$170.3K | -$154.9K | -$476.9K | -$394.3K | $322.6K | -$524.8K | -$318.6K | -$204.7K | -$316.0K | -$530.8K | -$1.3M | -$864.00 | -$1.5K | ||
| Operating Income Loss | -$103.9K | -$139.9K | -$140.0K | -$197.7K | -$203.0K | -$270.9K | -$731.6K | -$604.7K | -$81.2K | -$682.0K | -$618.4K | -$571.8K | -$458.7K | -$495.9K | -$1.6M | -$864.00 | -$1.5K | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$61.5K | -$98.6K | -$117.5K | -$120.5K | -$142.5K | -$127.2K | -$457.6K | -$330.9K | $378.7K | -$498.5K | -$218.4K | -$173.6K | -$316.0K | -$530.8K | -$1.3M | -$864.00 | |||
| Income Tax Expense Benefit | -$1.9K | -$1.7K | $2.5K | $39.5K | $27.8K | $27.7K | $19.3K | $63.4K | $56.1K | $26.4K | $100.2K | $31.1K | $0.00 | ||||||
| Accrued Income Taxes Current | $114.6K | $116.5K | $177.2K | $254.7K | $521.0K | $481.4K | $453.6K | $346.4K | $327.1K | $263.7K | $157.7K | $131.3K | $31.1K | ||||||
| General And Administrative Expense | $63.9K | $99.9K | $113.8K | $147.7K | $153.0K | $220.9K | $681.1K | $554.2K | $30.8K | ||||||||||
| Sales And Excise Tax Payable Current | $12.7K | $12.7K | $91.9K | $91.9K | $205.4K | $113.7K | $113.7K | $6.9K | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Stockholders Equity | -$11.1M | -$8.6M | -$8.2M | $0.00 | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $302.00 | $107.7K | $224.7K | $0.00 | ||
| Retained Earnings Accumulated Deficit | -$14.0M | -$11.1M | -$9.1M | -$8.8M | ||
| Liabilities And Stockholders Equity | $11.4M | $21.0M | $230.3M | $230.5M | ||
| Liabilities | $14.5M | $11.8M | $8.9M | $8.7M | ||
| Assets | $11.4M | $21.0M | $230.3M | $230.5M | ||
| Liabilities Current | $6.4M | $3.7M | $689.0K | $394.1K | ||
| Assets Current | $30.0K | $52.8K | $299.9K | $463.7K | ||
| Temporary Equity Carrying Amount Attributable To Parent | $10.9M | $20.3M | $230.0M | $230.0M | ||
| Common Stock Value | $655.00 | $655.00 | $655.00 | $655.00 | ||
| Accounts Payable And Accrued Liabilities Current | $1.7M | $1.2M | $414.0K | $394.1K | ||
| Temporary Equity Accretion To Redemption Value Adjustment | $2.0M | $1.3M | $33.7M | |||
| Assets Held In Trust Noncurrent | $11.4M | $21.0M | $230.0M | $230.0M | ||
| Deferred Underwriting Fee Payable | $8.1M | $8.1M | $8.1M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $240.5K | $742.00 | -$107.4K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$107.4K | $224.7K | ||||
| Deferred Offering Costs Noncurrent | $8.1M | $8.1M | ||||
| Liabilities Written Back | $142.3K | $314.7K | ||||
| Other Receivables Net Current | $10.0K | |||||
| Deferred Offering Costs Included In Promissory Notes Related Party | $0.00 | $213.5K | ||||
| Cash And Cash Equivalents At Carrying Value | ||||||
| Temporary Equity Accretion To Redemption Value | $359.6K | $2.0M | ||||
| Notes Payable Related Parties Classified Current | $2.1M | $195.0K | $0.00 | |||
| Warrant Liability At Fair Value Changes In Fair Value | ||||||
| Preferred Stock Value | $0.00 | $0.00 | ||||
| Interest And Dividend Income On Investments Held In Trust Account | $502.7K | $990.9K | ||||
| Cash Withdrawn From Trust Account In Connection With Redemption | $7.9M | $11.4M | ||||
| Other Liabilities Current | $656.9K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$15.1M | -$15.1M | -$15.0M | -$14.9M | -$14.9M | -$14.6M | -$14.3M | -$14.0M | -$13.3M | -$11.5M | -$10.9M | -$10.6M | -$9.8M | -$9.1M | -$7.7M | $22.6K | $23.5K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $161.4K | $241.5K | $325.2K | $247.00 | $1.0K | $1.2K | $7.1K | $185.5K | $159.0K | $80.6K | $43.8K | $438.0K | $25.8K | $7.0K | ||||||
| Retained Earnings Accumulated Deficit | -$15.1M | -$15.1M | -$15.0M | -$14.9M | -$14.9M | -$14.6M | -$14.3M | -$13.3M | -$11.5M | -$10.9M | -$10.6M | -$9.8M | -$9.3M | -$8.3M | -$2.4K | |||||
| Liabilities And Stockholders Equity | $3.5M | $3.5M | $3.6M | $3.6M | $12.0M | $11.8M | $11.7M | $22.0M | $21.4M | $21.6M | $22.3M | $21.7M | $230.5M | $230.8M | $524.2K | |||||
| Liabilities | $15.3M | $15.2M | $15.2M | $15.1M | $23.6M | $15.2M | $14.9M | $14.0M | $12.9M | $12.1M | $11.1M | $10.0M | $9.2M | $8.5M | $501.6K | |||||
| Assets | $3.5M | $3.5M | $3.6M | $3.6M | $12.0M | $11.8M | $11.7M | $22.0M | $21.4M | $21.6M | $22.3M | $21.7M | $230.5M | $230.8M | $524.2K | |||||
| Liabilities Current | $7.2M | $7.1M | $7.1M | $7.1M | $15.3M | $7.1M | $6.8M | $6.0M | $4.8M | $4.0M | $3.0M | $1.9M | $1.1M | $220.1K | ||||||
| Assets Current | $75.9K | $76.7K | $174.3K | $269.1K | $27.3K | $47.8K | $72.5K | $1.2K | $24.6K | $220.5K | $159.0K | $95.5K | $129.7K | $785.6K | ||||||
| Temporary Equity Carrying Amount Attributable To Parent | $3.4M | $3.4M | $3.4M | $3.4M | $3.4M | $11.2M | $11.1M | $21.3M | $20.0M | $20.4M | $21.5M | $230.3M | $230.0M | |||||||
| Common Stock Value | $655.00 | $655.00 | $655.00 | $655.00 | $655.00 | $655.00 | $655.00 | $655.00 | $655.00 | $655.00 | $655.00 | $655.00 | $575.00 | |||||||
| Accounts Payable And Accrued Liabilities Current | $963.6K | $951.1K | $1.0M | $957.6K | $1.7M | $1.6M | $1.6M | $1.9M | $1.6M | $1.0M | $995.0K | $694.6K | $535.6K | |||||||
| Temporary Equity Accretion To Redemption Value Adjustment | -$84.6K | $131.1K | -$150.8K | -$1.2M | -$275.9K | -$149.1K | $329.4K | $368.1K | $340.5K | $0.00 | $33.7M | |||||||||
| Assets Held In Trust Noncurrent | $3.4M | $3.4M | $3.4M | $3.4M | $12.0M | $11.8M | $11.6M | $21.4M | $22.1M | $21.6M | $230.3M | $230.0M | ||||||||
| Deferred Underwriting Fee Payable | $8.1M | $8.1M | $8.1M | $8.1M | $8.1M | $8.1M | $8.1M | $8.1M | $8.1M | $0.00 | $0.00 | $0.00 | ||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$80.2K | -$797.00 | $185.2K | |||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $185.2K | -$63.9K | -$117.0K | $7.0K | ||||||||||||||||
| Deferred Offering Costs Noncurrent | $8.1M | $8.1M | $8.1M | $8.1M | $8.1M | $8.1M | ||||||||||||||
| Liabilities Written Back | $0.00 | $0.00 | $200.0K | $0.00 | $0.00 | |||||||||||||||
| Other Receivables Net Current | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | |||||||||||||||
| Deferred Offering Costs Included In Promissory Notes Related Party | $0.00 | $0.00 | $0.00 | $181.7K | ||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | $159.0K | $80.6K | $43.8K | $107.7K | $224.7K | $438.0K | $25.8K | |||||||||||||
| Temporary Equity Accretion To Redemption Value | $1.7K | $12.5K | $84.6K | $131.1K | $150.8K | |||||||||||||||
| Notes Payable Related Parties Classified Current | $1.7M | $945.0K | $445.0K | $403.5K | ||||||||||||||||
| Warrant Liability At Fair Value Changes In Fair Value | -$12.8K | -$2.0K | $10.0K | $0.00 | $31.9K | $87.7K | ||||||||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||
| Interest And Dividend Income On Investments Held In Trust Account | ||||||||||||||||||||
| Cash Withdrawn From Trust Account In Connection With Redemption | -$6.0K | -$80.0K | ||||||||||||||||||
| Other Liabilities Current | $656.9K | $656.9K | $656.9K | $656.9K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Payments For Investment Of Cash In Trust Account | $188.0K | $1.1M | $1.1M | -$230.0M | |
| Net Cash Provided By Used In Operating Activities | -$1.9M | -$1.3M | -$1.2M | -$576.9K | |
| Net Cash Provided By Used In Financing Activities | -$6.3M | -$9.3M | -$209.0M | $230.8M | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$717.0K | $282.0K | $898.7K | $394.1K | |
| Increase Decrease In Prepaid Expense | -$1.4K | -$33.5K | -$139.7K | -$239.0K | |
| Net Cash Provided By Used In Investing Activities | $8.5M | $10.6M | $210.1M | -$230.0M | |
| Proceeds From Related Party Debt | $319.5K | $1.9M | $315.0K | ||
| Increase Decrease In Accrued Income Taxes Payable | -$171.2K | $218.3K | $207.6K | $0.00 | |
| Proceeds From Issuance Of Debt | $1.6M | $1.1M | |||
| Allocated Share Based Compensation Expense | $0.00 | $1.4M | $1.4M | ||
| Proceeds From Trust Account To Pay Franchise Tax | $755.0K | $324.7K | $245.3K | ||
| Proceeds From Trust Account In Connection With Redemption | $11.4M | $211.0M | $0.00 | ||
| Payments Of Stock Issuance Costs | $0.00 | $2.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q2 2025 | Q2 2024 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Payments For Investment Of Cash In Trust Account | $80.0K | $257.0K | $385.5K | $350.0K | $350.0K | $0.00 | $0.00 | |||
| Net Cash Provided By Used In Operating Activities | -$133.3K | -$431.6K | -$242.3K | -$313.9K | -$312.0K | -$525.00 | ||||
| Net Cash Provided By Used In Financing Activities | $59.2K | $510.8K | $583.6K | $250.0K | $195.0K | $7.5K | ||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $72.1K | -$117.4K | -$378.6K | $101.8K | $99.9K | $1.0K | ||||
| Increase Decrease In Prepaid Expense | -$14.7K | $43.3K | -$17.5K | $106.3K | $46.8K | |||||
| Net Cash Provided By Used In Investing Activities | -$6.0K | -$80.0K | -$156.1K | $0.00 | $0.00 | |||||
| Proceeds From Related Party Debt | $583.6K | $250.0K | $195.0K | $165.0K | ||||||
| Increase Decrease In Accrued Income Taxes Payable | -$77.5K | $27.7K | $56.1K | $81.0K | $0.00 | |||||
| Proceeds From Issuance Of Debt | $59.2K | $510.8K | ||||||||
| Allocated Share Based Compensation Expense | $0.00 | $0.00 | $0.00 | $1.4M | ||||||
| Proceeds From Trust Account To Pay Franchise Tax | $100.9K | |||||||||
| Proceeds From Trust Account In Connection With Redemption | $0.00 | |||||||||
| Payments Of Stock Issuance Costs | $0.00 | $107.5K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Diluted EPS * | -$0.06 | -$0.10 | -$0.08 | -$0.12 | |
| Weighted Average Number Of Shares Outstanding Basic | 7.4M | 8.3M | 15.3M | 15.2M | |
| Weighted Average Number Of Diluted Shares Outstanding | 7.4M | 8.3M | 15.3M | 15.2M | |
| Earnings Per Share Basic | $-0.06 | $-0.10 | $-0.08 | $-0.12 | |
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | ||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | ||
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | ||
| Common Stock Shares Outstanding | 6.5M | 6.5M | 6.5M | ||
| Common Stock Shares Issued | 6.5M | 6.5M | 6.5M | ||
| Temporary Equity Shares Outstanding | 975.5K | 2.0M | 23.0M | ||
| Temporary Equity Redemption Price Per Share | $11.20 | $10.28 | $10.00 | ||
| Temporary Equity Shares Issued | 975.5K | 2.0M | 23.0M | ||
| Preferred Stock Shares Outstanding | 0.00 | ||||
| Preferred Stock Shares Issued | 0.00 | ||||
| Earning Per Share Basic And Diluted | $-0.08 | $-0.12 | |||
| Weighted Average Shares Outstanding Basic And Diluted |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.01 | -$0.01 | -$0.02 | -$0.02 | -$0.02 | -$0.02 | -$0.06 | -$0.05 | $0.04 | -$0.06 | -$0.02 | -$0.01 | -$0.01 | -$0.02 | -$0.07 | $0.00 | $0.00 | ||
| Weighted Average Number Of Shares Outstanding Basic | 6.9M | 6.9M | 6.9M | 7.5M | 7.5M | 7.5M | 8.5M | 8.5M | 8.5M | 8.7M | 14.4M | 29.5M | 29.5M | 29.5M | 20.6M | 5.0M | 5.0M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 6.9M | 6.9M | 6.9M | 7.5M | 7.5M | 7.5M | 8.5M | 8.5M | 8.5M | 8.7M | 14.4M | 29.5M | 29.5M | 29.5M | 20.6M | 5.0M | 5.0M | ||
| Earnings Per Share Basic | $-0.01 | $-0.01 | $-0.02 | $-0.02 | $-0.02 | $-0.02 | $-0.06 | $-0.05 | $0.04 | $-0.06 | $-0.02 | $-0.01 | $-0.01 | $-0.02 | $-0.07 | $0.00 | $0.00 | ||
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 0.00 | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 10.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Outstanding | 6.5M | 6.5M | 6.5M | 6.5M | 6.5M | 6.5M | 6.5M | 6.5M | 6.5M | 6.5M | 6.5M | 6.5M | 6.5M | 6.5M | 5.8M | ||||
| Common Stock Shares Issued | 6.5M | 6.5M | 6.5M | 6.5M | 6.5M | 6.5M | 6.5M | 6.5M | 6.5M | 6.5M | 6.5M | 6.5M | 6.5M | 6.5M | 5.8M | ||||
| Temporary Equity Shares Outstanding | 289.7K | 289.7K | 289.7K | 289.7K | 289.7K | 975.5K | 975.5K | 1.9M | 1.9M | 2.0M | 23.0M | 23.0M | |||||||
| Temporary Equity Redemption Price Per Share | $11.80 | $11.81 | $11.77 | $11.66 | $11.65 | $11.49 | $11.36 | $11.13 | $10.48 | $10.36 | $10.03 | $0.10 | |||||||
| Temporary Equity Shares Issued | 289.7K | 289.7K | 289.7K | 289.7K | 289.7K | 975.5K | 975.5K | 1.9M | 1.9M | 2.0M | 23.0M | ||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Earning Per Share Basic And Diluted | $-0.06 | $-0.05 | $0.04 | $-0.06 | $-0.02 | $-0.01 | $-0.01 | ||||||||||||
| Weighted Average Shares Outstanding Basic And Diluted | 8.5M | 8.5M | 8.5M | 8.7M | 14.4M | 29.5M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Investment Income Interest And Dividend | $502.7K | $990.9K | $1.1M | $6.8K | |
| Fair Value Adjustment Of Warrants | -$12.7K | $7.2K | -$119.5K | $199.2K | |
| Prepaid Expense Current | $19.0K | $52.5K | $192.2K | $239.0K | |
| Operating Costs And Expenses | $2.2M | $737.0K | |||
| Accretion Of Public Shares To Redemption Value | 359.6K | 2.0M | 1.3M | 33.7M | |
| Franchisor Costs | $208.4K | $200.0K | $200.0K | ||
| Additional Paid In Capital | $564.6K | $564.6K | |||
| Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares | 143.4K | 263.0K | |||
| Warrants And Rights Outstanding | $31.1K | $23.9K | |||
| Offering Costs Incurred | $0.00 | $4.9K | |||
| Offering Costs Paid In Exchange For Private Units | $0.00 | $225.0K | |||
| Accretion Of Class A Ordinary Shares Subject To Redemption | |||||
| Repayment Of Promissory Note Through Issuance Of Private Units | $0.00 | $503.5K | |||
| Due To Affiliate Current | $200.0K | $80.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment Income Interest And Dividend | $30.0K | $34.1K | $35.3K | $132.1K | $148.9K | $148.5K | $286.7K | $275.9K | $250.0K | $183.5K | $368.1K | $310.6K | $23.2K | $4.9K | $1.9K | ||||
| Fair Value Adjustment Of Warrants | -$12.3K | -$7.2K | $12.8K | $55.0K | $88.5K | $4.8K | $12.8K | $2.0K | -$10.0K | -$31.9K | -$87.7K | $119.5K | $39.8K | -$239.1K | |||||
| Prepaid Expense Current | $19.1K | $19.9K | $2.9K | $17.6K | $17.3K | $37.8K | $62.3K | $0.00 | $17.5K | $35.0K | $14.9K | $85.9K | $347.5K | ||||||
| Operating Costs And Expenses | $731.6K | $604.7K | $81.2K | $682.0K | $618.4K | $571.8K | $458.7K | $495.9K | $233.8K | $864.00 | $1.5K | ||||||||
| Accretion Of Public Shares To Redemption Value | 12.5K | 150.8K | 149.1K | 340.5K | 0.00 | ||||||||||||||
| Franchisor Costs | $40.0K | $40.0K | $26.2K | $50.0K | $50.0K | $50.0K | $50.4K | $50.5K | $50.4K | ||||||||||
| Additional Paid In Capital | $0.00 | $0.00 | $0.00 | $224.1K | $564.6K | $24.4K | |||||||||||||
| Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares | 13.9K | 23.9K | 23.9K | 23.9K | 55.8K | 223.1K | |||||||||||||
| Warrants And Rights Outstanding | $11.6K | $23.9K | $31.1K | $18.3K | $179.3K | $124.3K | $35.9K | ||||||||||||
| Offering Costs Incurred | $0.00 | $0.00 | $0.00 | $4.9K | |||||||||||||||
| Offering Costs Paid In Exchange For Private Units | $0.00 | $0.00 | $0.00 | $25.0K | |||||||||||||||
| Accretion Of Class A Ordinary Shares Subject To Redemption | -1.2M | -275.9K | -149.1K | -329.4K | -368.1K | -340.5K | |||||||||||||
| Repayment Of Promissory Note Through Issuance Of Private Units | $0.00 | $0.00 | $0.00 | ||||||||||||||||
| Due To Affiliate Current | $170.0K | $140.0K | $110.0K |
Most recent annual filing with the SEC: July 15, 2025
Data sourced from SEC EDGAR public filings as of August 10, 2026.